Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02034097
Recruitment Status : Withdrawn (GSK has decided to terminate the Product Development of foretinib and conclude our Development Agreement with Exelixis)
First Posted : January 13, 2014
Last Update Posted : May 19, 2014
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : April 2014
Estimated Study Completion Date : December 2016